Sharp increase in revenue for the first half of 2022 of +58%, to €4.1 million (vs. H1 2021) 52% increase in gross margin in the first half of 2022, to €2.6 million Removal of the conditions
Fulfillment of all the conditions precedent, enabling the commercial, technological, and financial partnership with Sanyou Medical to be implemented Regulatory News: IMPLANET (Euronext Growth:
IMPLANET Reports Its Revenue for Q2 2022, Up 33% pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Commercial partnership: Agreement to distribute Implanet's JAZZ platform in China, the world's largest market (by volume) for spine surgery Technological partnership: Joint development of
Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral implants, informs